Therapy for treatment-refractory chronic Hepatitis C virus genotype 1b infection: A retrospective analysis


Creative Commons License

Cindoruk M., Karakan T., ÜNAL S.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, vol.66, no.5, pp.451-462, 2005 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 5
  • Publication Date: 2005
  • Doi Number: 10.1016/j.curtheres.2005.10.002
  • Title of Journal : CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
  • Page Numbers: pp.451-462

Abstract

Background: The most effective current therapy for hepatitis C virus (HCV) infection is the combination of pegylated interferon (peg-IFN) plus ribavirin (RBV).